U01EB031894
Cooperative Agreement
Overview
Grant Description
Quantitative MRI and deep learning technologies for classification of NAFLD.
Funding Goals
TO SUPPORT HYPOTHESIS-, DESIGN-, TECHNOLOGY-, OR DEVICE-DRIVEN RESEARCH RELATED TO THE DISCOVERY, DESIGN, DEVELOPMENT, VALIDATION, AND APPLICATION OF TECHNOLOGIES FOR BIOMEDICAL IMAGING AND BIOENGINEERING. THE PROGRAM INCLUDES BIOMATERIALS (BIOMIMETICS, BIOPROCESSING, ORGANOGENESIS, REHABILITATION, TISSUE ENGINEERING, IMPLANT SCIENCE, MATERIAL SCIENCE, INTERFACE SCIENCE, PHYSICS AND STRESS ENGINEERING, TECHNOLOGY ASSESSMENT OF MATERIALS/DEVICES), BIOSENSORS/BIOTRANSDUCERS (TECHNOLOGY DEVELOPMENT, TECHNOLOGY ASSESSMENT, DEVELOPMENT OF ALGORITHMS, TELEMETRY), NANOTECHNOLOGY (NANOSCIENCE, BIOMIMETICS, DRUG DELIVERY SYSTEMS, DRUG BIOAVAILABILITY, MICROARRAY/COMBINATORIAL TECHNOLOGY, GENETIC ENGINEERING, COMPUTER SCIENCE, TECHNOLOGY ASSESSMENT), BIOINFORMATICS (COMPUTER SCIENCE, INFORMATION SCIENCE, MATHEMATICS, BIOMECHANICS, COMPUTATIONAL MODELING AND SIMULATION, REMOTE DIAGNOSIS AND THERAPY), IMAGING DEVICE DEVELOPMENT, BIOMEDICAL IMAGING TECHNOLOGY DEVELOPMENT, IMAGE EXPLOITATION, CONTRAST AGENTS, INFORMATICS AND COMPUTER SCIENCES RELATED TO IMAGING, MOLECULAR AND CELLULAR IMAGING, BIOELECTRICS/BIOMAGNETICS, ORGAN AND WHOLE BODY IMAGING, SCREENING FOR DISEASES AND DISORDERS, AND IMAGING TECHNOLOGY ASSESSMENT AND SURGERY (TECHNIQUE DEVELOPMENT AND TECHNOLOGY DEVELOPMENT).
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
California
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the End Date has been extended from 04/28/27 to 04/30/27 and the total obligations have increased 289% from $608,300 to $2,364,000.
Los Angeles University Of California was awarded
Quantitative MRI and Deep Learning Technologies for Classification of NAFLD
Cooperative Agreement U01EB031894
worth $2,364,000
from the National Institute of Biomedical Imaging and Bioengineering in August 2022 with work to be completed primarily in California United States.
The grant
has a duration of 4 years 8 months and
was awarded through assistance program 93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health.
The Cooperative Agreement was awarded through grant opportunity Bioengineering Research Partnerships (U01 Clinical Trial Not Allowed).
Status
(Ongoing)
Last Modified 6/5/25
Period of Performance
8/1/22
Start Date
4/30/27
End Date
Funding Split
$2.4M
Federal Obligation
$0.0
Non-Federal Obligation
$2.4M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for U01EB031894
Transaction History
Modifications to U01EB031894
Additional Detail
Award ID FAIN
U01EB031894
SAI Number
U01EB031894-2451489137
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75N800 NIH National Institute of Biomedical Imaging and Bioengineering
Funding Office
75N800 NIH National Institute of Biomedical Imaging and Bioengineering
Awardee UEI
RN64EPNH8JC6
Awardee CAGE
4B557
Performance District
CA-90
Senators
Dianne Feinstein
Alejandro Padilla
Alejandro Padilla
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Health and Human Services (075-0898) | Health research and training | Grants, subsidies, and contributions (41.0) | $1,183,175 | 100% |
Modified: 6/5/25